Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group

Clicks: 489
ID: 113887
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 37 articles by views in the journal of pediatrics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Ribavirin administration during mechanical ventilation to previously well infants with RSV infection was not associated with reductions in either mortality rates or duration of mechanical ventilation. Additional clinical effectiveness studies are required to define specific groups in which the use o …
Reference Key
fw1996theeffectiveness Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Moler FW;Steinhart CM;Ohmit SE;Stidham GL;;
Journal the journal of pediatrics
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8774517
Keywords
respiration Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome female male Infant Comparative Study Prospective Studies newborn Multicenter Study inhalation Artificial severity of illness index case-control studies Cohort Studies respiratory syncytial virus infections / therapy multivariate analysis aerosols antiviral agents / administration & dosage antiviral agents / therapeutic use* ribavirin / administration & dosage ribavirin / therapeutic use* respiratory syncytial virus infections / drug therapy* respiratory syncytial virus infections / mortality respiratory syncytial virus human* respiratory syncytial virus infections / complications pmid:8774517 doi:10.1016/s0022-3476(96)70294-9 f w moler c m steinhart g l stidham premature respiratory insufficiency / drug therapy* respiratory insufficiency / mortality respiratory insufficiency / therapy respiratory insufficiency / virology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.